|
Japão Tobacco Inc. (2914.T) Avaliação DCF
JP | Consumer Defensive | Tobacco | JPX
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Japan Tobacco Inc. (2914.T) Bundle
Simplifique sua análise e melhore a precisão com a calculadora DCF do Japan Tobacco Inc. (2914T)! Equipado com dados reais do Japão Tobacco e suposições personalizáveis, essa ferramenta o capacita a prever, avaliar e valorizar o Japão Tobacco Inc. (2914T) como um investidor experiente.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,175,626.0 | 2,092,561.0 | 2,324,838.0 | 2,657,832.0 | 2,841,077.0 | 3,043,503.7 | 3,260,353.4 | 3,492,653.5 | 3,741,505.1 | 4,008,087.3 |
| Revenue Growth, % | 0 | -3.82 | 11.1 | 14.32 | 6.89 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 |
| EBITDA | 677,996.0 | 622,714.0 | 687,127.0 | 829,173.0 | 824,778.0 | 917,345.2 | 982,706.0 | 1,052,723.8 | 1,127,730.4 | 1,208,081.2 |
| EBITDA, % | 31.16 | 29.76 | 29.56 | 31.2 | 29.03 | 30.14 | 30.14 | 30.14 | 30.14 | 30.14 |
| Depreciation | 183,319.0 | 179,292.0 | 186,999.0 | 199,372.0 | 179,652.0 | 236,555.2 | 253,409.7 | 271,465.1 | 290,807.0 | 311,527.0 |
| Depreciation, % | 8.43 | 8.57 | 8.04 | 7.5 | 6.32 | 7.77 | 7.77 | 7.77 | 7.77 | 7.77 |
| EBIT | 494,677.0 | 443,422.0 | 500,128.0 | 629,801.0 | 645,126.0 | 680,790.0 | 729,296.3 | 781,258.7 | 836,923.4 | 896,554.1 |
| EBIT, % | 22.74 | 21.19 | 21.51 | 23.7 | 22.71 | 22.37 | 22.37 | 22.37 | 22.37 | 22.37 |
| Total Cash | 379,101.0 | 557,672.0 | 738,985.0 | 904,562.0 | 1,040,206.0 | 891,798.7 | 955,339.4 | 1,023,407.3 | 1,096,325.1 | 1,174,438.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 430,400.0 | 402,797.0 | 475,615.0 | 499,139.0 | 535,302.0 | 591,116.8 | 633,233.9 | 678,351.8 | 726,684.4 | 778,460.7 |
| Account Receivables, % | 19.78 | 19.25 | 20.46 | 18.78 | 18.84 | 19.42 | 19.42 | 19.42 | 19.42 | 19.42 |
| Inventories | 677,586.0 | 539,762.0 | 563,182.0 | 691,906.0 | 832,611.0 | 830,890.0 | 890,090.9 | 953,509.8 | 1,021,447.4 | 1,094,225.5 |
| Inventories, % | 31.14 | 25.79 | 24.22 | 26.03 | 29.31 | 27.3 | 27.3 | 27.3 | 27.3 | 27.3 |
| Accounts Payable | 160,371.0 | 187,261.0 | 555,777.0 | 540,089.0 | 592,802.0 | 495,557.0 | 530,865.5 | 568,689.6 | 609,208.8 | 652,614.9 |
| Accounts Payable, % | 7.37 | 8.95 | 23.91 | 20.32 | 20.87 | 16.28 | 16.28 | 16.28 | 16.28 | 16.28 |
| Capital Expenditure | -133,370.0 | -108,620.0 | -102,918.0 | -99,408.0 | -121,214.0 | -144,593.9 | -154,896.3 | -165,932.6 | -177,755.3 | -190,420.4 |
| Capital Expenditure, % | -6.13 | -5.19 | -4.43 | -3.74 | -4.27 | -4.75 | -4.75 | -4.75 | -4.75 | -4.75 |
| Tax Rate, % | 22.41 | 22.41 | 22.41 | 22.41 | 22.41 | 22.41 | 22.41 | 22.41 | 22.41 | 22.41 |
| EBITAT | 370,227.3 | 327,506.7 | 358,365.6 | 469,834.0 | 500,541.6 | 507,249.2 | 543,390.7 | 582,107.3 | 623,582.4 | 668,012.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -527,438.7 | 590,495.7 | 714,724.6 | 401,862.0 | 434,824.6 | 447,871.6 | 575,894.6 | 616,927.1 | 660,883.1 | 707,971.0 |
| WACC, % | 5.51 | 5.5 | 5.47 | 5.51 | 5.55 | 5.51 | 5.51 | 5.51 | 5.51 | 5.51 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 2,541,810.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 722,130 | |||||||||
| Terminal Value | 20,578,863 | |||||||||
| Present Terminal Value | 15,738,815 | |||||||||
| Enterprise Value | 18,280,625 | |||||||||
| Net Debt | 102,053 | |||||||||
| Equity Value | 18,178,572 | |||||||||
| Diluted Shares Outstanding, MM | 1,776 | |||||||||
| Equity Value Per Share | 10,238.24 |
What You Will Receive
- Authentic Japan Tobacco Data: Preloaded financial metrics – from revenue to EBIT – based on actual and projected data.
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Adjustments: Automatic recalculations to evaluate the effects of changes on Japan Tobacco’s fair value.
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and thorough projections.
- Efficient and Precise: Avoid the hassle of building models from scratch while ensuring accuracy and adaptability.
Key Features
- Pre-Loaded Data: Japan Tobacco Inc.'s historical financial statements and pre-filled forecasts.
- Fully Adjustable Inputs: Customize WACC, tax rates, revenue growth, and EBITDA margins.
- Instant Results: Watch Japan Tobacco Inc.'s intrinsic value update in real time.
- Clear Visual Outputs: Dashboard charts visualize valuation results and key metrics.
- Built for Accuracy: A professional tool tailored for analysts, investors, and finance professionals.
How It Works
- 1. Access the Template: Download and open the Excel file containing Japan Tobacco Inc.'s ([2914T]) preloaded data.
- 2. Modify Assumptions: Adjust key variables such as growth rates, WACC, and capital expenditures.
- 3. View Instant Results: The DCF model automatically calculates the intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate multiple forecasts to assess various valuation possibilities.
- 5. Present with Confidence: Share professional valuation insights to back your investment decisions.
Why Opt for This Calculator for Japan Tobacco Inc. (2914T)?
- All-in-One Tool: Combines DCF, WACC, and financial ratio analyses for comprehensive assessment.
- Flexible Inputs: Modify the highlighted yellow cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes Japan Tobacco's intrinsic value and Net Present Value.
- Preloaded Information: Utilizes historical and projected data for reliable starting points.
- High-Quality Standards: Perfect for financial analysts, investors, and business advisors.
Who Can Benefit from This Product?
- Investors: Accurately assess the fair value of Japan Tobacco Inc. (2914T) prior to making investment choices.
- CFOs: Utilize a high-caliber DCF model for precise financial reporting and analysis.
- Consultants: Easily customize the template for valuation reports tailored to clients.
- Entrepreneurs: Acquire knowledge of financial modeling practices adopted by leading corporations.
- Educators: Implement it as a teaching resource to illustrate valuation techniques.
What the Template Contains
- Historical Data: Provides Japan Tobacco Inc.'s (2914T) previous financial results and foundational forecasts.
- DCF and Levered DCF Models: Comprehensive templates for estimating the intrinsic value of Japan Tobacco Inc. (2914T).
- WACC Sheet: Pre-constructed calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Adjust key factors such as growth rates, EBITDA percentages, and CAPEX projections.
- Quarterly and Annual Statements: A thorough analysis of Japan Tobacco Inc.'s (2914T) financial performance.
- Interactive Dashboard: Visually represent valuation outcomes and forecasts in an engaging manner.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.